152:HKEXKian Shen Corporation Analysis
Data as of 2026-03-17 - not real-time
NT$61.40
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical outlook is bearish as the price sits below its short‑term moving averages and the MACD line is under the signal, generating a bearish histogram. Momentum indicators such as the RSI sit in a neutral zone, offering limited upside, while volume trends are weakening, suggesting reduced buying pressure.
On the fundamentals side, the stock appears undervalued with a price‑to‑book below parity and a dividend yield that ranks among the higher tier in its sector. However, the company is experiencing negative operating and free cash flow and a high payout ratio, raising questions about the sustainability of the dividend. The balance sheet is strong in cash relative to debt, but the ongoing cash‑flow deficit tempers confidence. Overall, the blend of bearish technical signals and mixed fundamental health points to a cautious stance, with short‑term pressure but potential longer‑term value if cash‑flow dynamics improve.
On the fundamentals side, the stock appears undervalued with a price‑to‑book below parity and a dividend yield that ranks among the higher tier in its sector. However, the company is experiencing negative operating and free cash flow and a high payout ratio, raising questions about the sustainability of the dividend. The balance sheet is strong in cash relative to debt, but the ongoing cash‑flow deficit tempers confidence. Overall, the blend of bearish technical signals and mixed fundamental health points to a cautious stance, with short‑term pressure but potential longer‑term value if cash‑flow dynamics improve.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- price below short‑term moving averages
- bearish MACD divergence
- declining trading volume
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- undervalued valuation metrics
- strong cash reserves relative to debt
- high dividend yield offset by cash‑flow weakness
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- low beta indicating limited market volatility
- potential for cash‑flow turnaround
- sector cyclicality offering upside in recovery phases
Key Metrics & Analysis
Financial Health
Revenue Growth-18.00%
Profit Margin22.34%
P/E Ratio15.9
ROE5.87%
ROA0.45%
Debt/Equity1.89
P/B Ratio0.9
Op. Cash FlowNT$-34549000
Free Cash FlowNT$-49701376
Technical Analysis
TrendBearish
RSI41.1
SupportNT$60.60
ResistanceNT$65.00
MA 20NT$62.59
MA 50NT$63.03
MA 200NT$64.34
MACDBearish
VolumeDecreasing
Fear & Greed Index80.61
Valuation
GradeUndervalued
TypeValue
Dividend Yield4.55%
Risk Assessment
Beta0.57
Volatility21.87%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.